The modulatory effects of Bradykinin B1 and B2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia

Pain

Volumn 75, Issue 2-3, 1998, Pages 169-176

  Jaggar, Siân I ^a   Habib, Sheeren ^a   Rice, Andrew S C ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cystitis; Desg9 Leu8 bradykinin; HOE 140; Inflammation; Interstitial; Nociception; Pain; Urinary bladder

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; TURPENTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL CYSTITIS; CONTROLLED STUDY; DRUG EFFECT; EXTRAVASATION; FEMALE; HYPERREFLEXIA; INTRAARTERIAL DRUG ADMINISTRATION; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT; VISCERAL PAIN;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRADYKININ; COLORING AGENTS; CYSTITIS; EVANS BLUE; FEMALE; HYPERALGESIA; RATS; RATS, WISTAR; RECEPTORS, BRADYKININ; REFLEX, ABNORMAL; URINARY BLADDER; VISCERA;

EID: 0031924008     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00217-0     Document Type: Article

References (43)

1. Bathon J.M., Proud D. Bradykinin antagonists. Annu. Rev. Pharmacol. Toxicol. 31:1991;129-162.
2. Beresford I.J.M., Birch P.J. Antinociceptive activity of the bradykinin antagonist HOE 140 in rat and mouse. Br. J. Pharmacol. 105:1992;135P.
3. Bianchi M., Panerai A.E. The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. Br. J. Pharmacol. 117:1996;130-132.
4. Birder L.A., De Groat W.C. Increased c-fos expression in spinal neurones after irritation of the lower urinary tract in the rat. J. Neurosci. 12:1992;4878-4883.
5. 9-bradykinin in vitro and in vivo. Br. J. Pharmacol. 92:1987;257-264.
6. 2 bradykinin receptor knockout mice. Immunopharmacology. 33:1996;333-335.
7. 1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis. Br. J. Pharmacol. 114:1995;612-617.
8. Campos M.M., Calixto J.B. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema. Br. J. Pharmacol. 114:1995;1005-1013.
9. Correa C.R., Calixto J.B. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol. 110:1993;193-198.
10. Damas J., Remacle-Volon G. Influence of a long-acting bradykinin antagonist, HOE 140, on some acute inflammatory reactions in rat. Eur. J. Pharmacol. 211:1992;81-86.
11. Dmitrieva N., Iqbal R., Shelton D.L., McMahon S.B. c-fos Induction in a rat model of cystitis: role of NGF. Soc. Neurosci. Abstr. 22:1996;751.
12. Dmitrieva N., Shelton D.L., Rice A.S.C., McMahon S.B. The role of nerve growth factor in a model of visceral inflammation. Neuroscience. 78:1997;449-459.
13. Dmitrieva N., McMahon S.B. Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain. 66:1996;87-97.
14. Dray A., Bevan S. Inflammation and hyperalgesia: highlighting the team effort. Trends Pharmacol. Sci. 14:1993;287-290.
15. Dray A., Perkins M.P. Bradykinin and inflammatory pain. Trends Neurosci. 3:1993;99-104.
16. Farmer S.G., McMillan B.A., Meeker S.N., Burch R.M. Induction of vascular smooth muscle bradykinin B1 receptors in vivo during antigen arthritis. Agents Actions. 34:1991;191-193.
17. Habler H., Janig W., Koltzenburg M. A novel type of unmyelinated chemosensitive nociceptor in the acutely inflamed urinary bladder. Agents Actions. 25:1988;219-221.
18. Khasar S.G., Miao F.J., Levine J.D. Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia in the rat. Neuroscience. 69:1995;685-690.
19. Lecci A., Giuliani S., Meini S., Maggi C.A. Pharmacological analysis of the local and reflex responses to bradykinin on rat urinary bladder motility in vivo. Br. J. Pharmacol. 114:1995;708-714.
20. Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19:1996;514-520.
21. Lowe E.M., Anand P., Terenghi G., Williams-Chestnut R.E., Sinicropi D.V., Osborne J.L. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br. J. Urol. 79:1997;572-577.
22. Lundeberg T., Liedberg H., Nordling L., Theodorsson E., Owzarski A., Ekman P. Interstitial cystitis: correlation with nerve fibres, mast cells and histamine. Br. J. Urol. 71:1993;427-429.
23. Maggi C.A., Santicioli P., Del Bianco E., Lecci A., Giuliani S. Evidence for the involvement of bradykinin in chemically-evoked cystitis in anaesthetised rats. Arch. Pharmacol. 347:1993;432-437.
24. Manning, D.C. and Snyder, S.H., Bradykinin receptors localised by quantitative autoradiography in kidney, ureter and bladder, Am. J. Physiol., (1989) F909-F915.
25. 1 receptors: a review. Immunopharmacology. 30:1995;1-26.
26. McMahon S.B., Sykova E., Wall P.D., Woolf C.J., Gibson S. Neurogenic exstravasation and substance P levels are low in muscle as compared to skin. Neurosci. Lett. 52:1984;235-240.
27. McMahon S.B. Neuronal and behavioural consequences of chemical inflammation of the rat urinary bladder. Agents Actions. 25:1988;231-233.
28. McMahon, S.B., Mechanisms of cutaneous, deep and visceral pain. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, Churchill Livingstone, London, Vol. 3, 1994, pp. 129-152.
29. McMahon S.B., Dmitrieva N., Koltzenburg M. Visceral pain. Br. J. Anaesthesia. 75:1995;132-144.
30. McMahon S.B., Abel C. A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals. Pain. 28:1987;109-127.
31. McMahon S.B., Koltzenburg M. Novel classes of nociceptors: beyond Sherrington. Trends Neurosci. 13:1990;199-201.
32. McMahon, S.B. and Koltzenburg, M., Silent afferents and visceral pain. In: H.L. Fields and J.C. Liebeskind (Eds.), Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues, IASP press, Seattle, WA, 1994, pp. 11-30.
33. Meini S., Lecci A., Maggi C.A. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors. Br. J. Pharmacol. 117:1996;1619-1624.
34. Neppl H., Neuhof F., Afflerbach F., Neppl J.L.P., Berghofer A. Bradykinin-induced oedema formation proceeds from B2 receptor stimulation and is potentiated by concomitantly released prostaglandins. Acta Physiol. Scand. 142:1991;141-147.
35. Oddiah, D., McMahon, S.B. and Rattray, M., Inflammation produces up-regulation of neurotrophin messenger RNA in bladder, Soc. Neurosci. Abstr., 21 (1995) 604.15.
36. Pang X., Marchand J., Sant G.R., Kream R.M., Theoharides T.C. Increased numbers of substance P positive nerve fibres in interstitial cystitis. Br. J. Urol. 75:1995;744-750.
37. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol. 110:1993;1441-1444.
38. 8]-BK and HOE 140, in 2 models of persistent hyperalgesia in the rat. Pain. 53:1993;191-197.
39. Rice A.S.C. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain. Neurosci. Lett. 187:1995;111-114.
40. Rice A.S.C., McMahon S.B. Pre-emptive intra-thecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral pain. Pain. 57:1994;335-340.
41. Rueff A., Dawson A.J.L.R., Mendell L.M. Characteristics of nerve growth factor induced hyperalgesia in adult rats: dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain. 66:1996;359-372.
42. Sufka K.J., Roach J.T. Stimulus properties and antinociceptive effects of selective bradykinin B1 and B2 receptor antagonists in rats. Pain. 66:1996;99-103.
43. Woolf C.J., Safieh-Garabedian B., Ma Q., Crilly P., Winters J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 62:1994;327-331.